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Endothelial cellsKaposi's sarcoma (KS) herpesvirus (KSHV) is the etiological agent of several immunodeﬁciency-linked
cancers, including KS. Our previous work showed that the proto-oncogene c-kit is upregulated in KSHV-
infected endothelial cells (ECs), as well as in KS lesions. We show here that KSHV-dependent induction of
both c-kit mRNA and protein requires the establishment of a latent infection and that this upregulation
occurs in primary DMVECs as well as in immortalized DMVECs (eDMVECs). Interestingly, we ﬁnd that while
the lymphatic EC (LEC) subpopulation exhibits KSHV-induced c-Kit upregulation, the blood EC (BEC)
subpopulation does not. Despite this upregulation of c-Kit, receptor activation and phosphorylation of
downstream effectors such as MAP Kinase Erk 1/2 and GSK-3 still requires the addition of exogenous c-Kit
ligand, stem cell factor (SCF). These data indicate that KSHV does not induce constitutive c-Kit signaling, but
instead upregulates c-Kit receptor levels, thus allowing infected ECs to respond to endogenous and
exogenous SCF. Nonetheless, inhibition of either c-Kit activation or its downstream effectors reverses the
characteristic spindle phenotype of infected eDMVECs. Together, these results contribute to our overall
understanding of the role that the c-kit proto-oncogene plays in KS pathogenesis.© 2009 Elsevier Inc. All rights reserved.Introduction
KSHV/HHV8 is an oncogenic γ-herpesvirus from the Rhadinovirus
genus and is associated with several immunodeﬁciency-linked
cancers, including Kaposi's sarcoma (KS). KS is the most prevalent
malignancy affecting AIDS patients, and it has become the most
common cancer in sub-Saharan Africa, where KSHV is endemic and
HIV is widespread. Unlike most tumors that arise from the expansion
of a single transformed cell, KS tumors are most often polyclonal (Gill
et al., 1998). The majority of cells that comprise a KS lesion have a
distinctive spindle morphology and express endothelial markers such
as CD31 and CD34 (Nickoloff, 1991, 1993). However, cells expressing
macrophage, ﬁbroblast and smooth muscle cell markers have also
been identiﬁed within KS lesions (Uccini et al., 1994, 1997). Over the
past 15 years many studies have been published in an attempt to
pinpoint the exact origin of these cells (reviewed in Ganem (2006).
Initial studies based on histology and tumor location suggested that
the spindle cells (SCs) were of lymphatic EC (LEC) origin (Beckstead
et al., 1985). The majority of SCs express lymphatic-speciﬁc markers
such as lymphatic endothelial hyaluronan receptor-1 (LYVE-1), D2-40,
VEGFR-3 and podoplanin, but factor VIII and PAL-E, which aremarkers
for blood vascular ECs (BECs), have also been identiﬁed (Jussila et al.,ll rights reserved.1998; Kahn et al., 2002; Nadimi et al., 1988; Weninger et al., 1999; Xu
et al., 2004). In addition, KS lesions are not found in areas devoid of
lymphatics, such as the brain (Herndier and Ganem, 2001). Recently,
two groups have used microarray analysis to further address this
question. Using comparative transcriptomics (Wang et al., 2004), one
group found that the gene expression proﬁle of KS tissue was more
similar to ECs than that of any other cell type, and that the KS proﬁle
more closely matched that of LECs than BECs, thus conﬁrming the
majority of the histology data. The most intriguing results were
obtained from the comparison of the transcriptomes of both infected
and uninfected LECs and BECs. It appears that KSHV can efﬁciently
infect both cell types, resulting in a reprogramming that makes each
cell type more closely resemble the other. A similar transcriptomic
analysis of KSHV-infected BECs also concluded that infected BECs are
reprogrammed towards a more lymphatic expression proﬁle, as
evidenced by the upregulation of the lymphatic-speciﬁc marker
prospero-related homeobox-1 (PROX-1) (Hong et al., 2004). To a large
extent, the determination of the mechanisms of KSHV-induced
tumorigenesis has been hampered by the inability to identify truly
relevant KSHV target cells and to culture KS cells as explant cultures
that maintain the viral genome. The inability to grow infected KS-
derived cells led us to develop an in vitro endothelial cell infection
model to facilitate KSHV pathogenesis studies. We have previously
described a model system that utilizes HPV E6/E7-immortalized
dermal microvascular ECs (eDMVECs) that are chronically infected
(∼4 weeks) with KSHV (Moses et al., 1999). In this system, KSHV-
infected eDMVECs develop a KS-like spindle phenotype and exhibit
175J.L. Douglas et al. / Virology 390 (2009) 174–185features of transformation, particularly the capacity to grow post
conﬂuence to form multi-layered foci. A subsequent cDNA microarray
analysis of cellular genes upregulated by KSHV infection identiﬁed
several proto-oncogenes including c-kit, the receptor for stem cell
factor (SCF, also mast cell growth factor, steel factor, Kit ligand)
(Moses et al., 2002a). Further study revealed that the KSHV-induced
upregulation of c-kit was necessary for the transformed phenotype
that develops in eDMVECs with time post-infection, suggesting that
c-kit may play a role in KS development. It was subsequently shown
that c-kit is strongly expressed in KS biopsies representing all
epidemiologic and histologic forms of KS (Pantanowitz et al., 2004,
2005). These results led to a clinical study that demonstrated the
efﬁcacy of the tyrosine kinase inhibitor Gleevec for KS tumor
regression (Koon et al., 2005).
c-Kit is a member of the PDGF family of receptor tyrosine kinases
and is normally expressed on hematopoietic stem cells, mast cells,
melanocytes, and germ cells. The receptor is activated by oligomer-
ization, which is triggered by the binding of its ligand SCF (reviewed in
Lennartsson et al. (2005b)). Ligand-dependent auto-phosphorylation
of c-Kit results in a series of downstream signaling events that include
the activation of various kinase pathways such as Ras/Erk, phosphoi-
nositide 3′-kinase, JAK/STAT, Src family kinase, and phospholipase Cγ
(Lennartsson et al., 2005a). SCF stimulation of c-Kit and synergy with
other cytokines results in cell survival and proliferation. However,Fig. 1. c-kitmRNA levels, late and lytic viral protein expression and viral copy number during
infection, eDMVECs (A) and primary DMVECs (D) were either mock (grey bars) or KSHV-
indicated times, qPCR for c-kit and gapdh was performed and c-kit levels were then norm
infection timecourses. To analyze late and lytic viral protein expression, KSHV-infected eDM
percentages of positive cells in 5 imaged ﬁelds are depicted in the graph. To quantitate the v
and qPCR for ORF26 and gapdh was performed (C). The ORF26 copy number relative to the c
duplicate qPCR reactions.oncogenesis can occur when SCF is secreted constitutively, or when
c-Kit is either overexpressed or mutated to allow ligand-independent
activation (Lennartsson et al., 2005b).
To further characterize the transformation of ECs by KSHV, we have
undertaken an analysis of c-Kit expression and signaling. Here we
show that virus-induced over-expression of c-Kit rather than aberrant
c-Kit activation is responsible for KSHV's transforming capability.
Moreover, we show that this c-kit upregulation is cell type dependent
and only occurs in lymphatic, but not blood ECs.
Results
c-kit mRNA is signiﬁcantly induced only in latently KSHV-infected
eDMVECs
We have previously described amicroarray analysis to characterize
the transcriptome of eDMVECs latently infected with KSHV (Moses
et al., 2002a). This was done in an effort to identify cellular genes
involved in KSHV-dependent transformation, and minimize the
contribution of genes involved in acute responses to viral infection.
One of the KSHV-induced genes identiﬁed in this screen was c-kit. In
order to determine the kinetics of c-kit upregulation during KSHV
infection, we infected eDMVECs with virus puriﬁed from PMA-
stimulated BCBL cells and then cultured these cells without passagea KSHV infection. To assess the kinetics of c-kit upregulation during a long-term KSHV
infected (black bars) as described in Materials and methods. RNA was isolated at the
alized to gapdh levels. The data shown is representative of at least two independent
VECs were ﬁxed and stained for ORF73 (late) and ORF59 (lytic) viral proteins (B). The
iral copy number for the eDMVEC infection, DNA was isolated from the indicated times
opies of gapdh is shown in the graph. Error bars represent the standard deviation from
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and mock-infected eDMVECs and Real-time quantitative PCR (qPCR)
was performed to measure the levels of c-kit message. gapdh mRNA
levels were used for normalization. Fig. 1A shows that c-kit levels
began to increase in the KSHV-infected eDMVECs by day 8 post
infection (PI), but were not signiﬁcantly upregulated until day 12. c-
Kit message levels in mock-infected eDMVECs remained low
throughout the timecourse. Interestingly, these mRNA levels corre-
late with the degree of spindle cells in the culture (data not shown).
To conﬁrm that viral latency had been established, expression of
both a latent (ORF73) and an early lytic (ORF59) protein were
measured via immunoﬂuorescent staining of infected monolayers
and counting of positive cells. As shown in Fig. 1B, latent protein
expression was detectable at day 4 PI in approximately 25% of the
cells compared to b1% expressing ORF59. Lytic protein expression
remained at a similar low level throughout the timecourse, while
latent protein expression increased to an average of 55–60%. To
determine if c-kit message levels correlated with an increase in viral
copy number, DNA was isolated at each of the timecourse intervals
and viral copy number was measured by qPCR of the ORF26 gene. As
shown in Fig. 1C, the viral copy number increased between day 4 and
day 8 PI and then did not signiﬁcantly change throughout the
remainder of the timecourse. Therefore the viral copy number
peaked several days before the observed c-kit upregulation. These
data suggest that the KSHV-induced increase in c-kit occurs after the
establishment of latency and requires a certain viral load threshold
and/or accumulation of a viral or virally-induced factor.
c-Kit upregulation also occurs in latently-infected primary DMVECs
The eDMVEC system that we previously developed to study
transformation by KSHV depends upon the prior immortalization of
primary DMVECs with the papillomavirus E6 and E7 gene products to
create a life-extended cell line (Moses et al., 1999). To conﬁrm that c-
kit upregulationwas not an artifact of this immortalization process, we
repeated the KSHV infection timecourse experiments in primary
DMVECs. As seen in Fig. 1D, qPCR revealed a similar latent expression
pattern for KSHV-induced c-kit upregulation in primary DMVECs
compared to eDMVECs. However, the overall levels of c-kit were
signiﬁcantly lower in the primary DMVECs (compare scale of Figs. 1A–
D). This was not due to a lower infection efﬁciency, as the viral copy
number in the primary DMVECs was equivalent to the viral copy
number in the eDMVECs (data not shown). The efﬁcient KSHV-
induction of c-Kit in E6/E7-expressing cells may recapitulate the
tumor microenvironment where additional factors likely exacerbate
KSHV-associated KS lesion growth.
c-Kit receptor expression is upregulated in KSHV-infected eDMVECs
To conﬁrm that the increased c-kit message levels in KSHV-
infected cells correlated with an increase in c-Kit protein expression
and proper cell surface localization, immunoprecipitation/immuno-
blot analysis of latently-infected eDMVECs and ﬂow cytometric
analysis of a KSHV infection timecourse were performed. Fig. 2A
shows that only KSHV-infected eDMVECs and the positive Ad-c-KitFig. 2. c-Kit protein expression and cell surface localization. To verify that the upregulatio
properly localized to the cell surface, immunoprecipitation/immunoblots (A) and ﬂow cy
eDMVECs. (A) Total c-Kit protein levels were determined by a combination of c-Kit immu
upper panel) Flow cytometric analysis for cell surface c-Kit was performed on Mock-inf
stained with a c-Kit antibody conjugated to PE and the shaded areas represent cells stained
cell surface c-Kit was performed on KSHV-infected eDMVECs at the indicated days post in
and the shaded areas represent cells stained with a PE-conjugated isotype control. Ad-c-K
number as the percent maximum and the X-axis represents PE ﬂuorescence intensity. (C)
eDMVECs at 3 weeks post-infection. The solid line represents GFP-positive cells stained w
stained with the same c-Kit antibody and the shaded histogram represents cells stainedcontrol express an appreciable level of c-Kit compared to mock-
infected eDMVECs. Immunoblot analysis alone was not sufﬁcient to
consistently visualize c-Kit expression unless it was overexpressed by
adenovirus (data not shown). The ﬂow cytometric analysis in Fig. 2B
indicates that cell surface expression of c-Kit in KSHV-infected
eDMVECs follows the same pattern of upregulation seen with the
c-kitmessage (compare Fig. 2B to Fig.1A). However, while the increase
in c-kit message is detectable at 8 days, the protein expression is not
evident until 13 days post infection. Despite this delay, the kinetics of
c-Kit protein induction in infected eDMVEC cultures is consistent with
KSHV-induced c-kitmRNA levels in latently-infected cells.
To determine whether the induction of c-Kit only occurs in those
cells directly infected with KSHV and is not due to a bystander effect,
we utilized the recombinant GFP-expressing KSHV, rKSHV.219 (Vieira
and O'Hearn, 2004) (kindly provided by Jeff Vieira). Cells infected
with this recombinant KSHV express GFP allowing us to use GFP
expression as a marker for viral infection. As shown in Fig. 2C only the
GFP-positive population of cells exhibited an increase in surface c-Kit
expression, suggesting a direct correlation between c-Kit induction
and KSHV infection. The GFP negative population of cells expressed no
detectable c-Kit when compared to the isotype control, indicating that
c-Kit is not induced merely by proximity to infected cells.
This recombinant virus also allowed us to determine whether the
induction of c-Kit was a consequence of viral spread through the
culture. Accordingly, eDMVECs were infected with rKSHV.219 and
cultured for 20 days. Samples were collected at 4 day intervals and
analyzed by ﬂow cytometry for both GFP (as a measure of viral
infection) and c-Kit expression. As shown in Fig. 3 (top panels), virus
was detected in 17% of the cells at day 4 and increased only 2 fold to a
ﬁnal level of 32% by day 20. In contrast (bottom panels), c-Kit
expression was not detectable at day 4 in the GFP+ KSHV-infected
cells, but was evident on day 8. From day 8 to day 20 the levels of c-Kit
remained consistent and only present in the GFP+ population of cells.
We conclude that the signiﬁcant increase in c-Kit levels at day 8 is not
due simply to an increase in the quantity of virally-infected cells, as
the percentage of KSHV-infected cells did not signiﬁcantly change
between day 4 and day 8. However, both the viral copy number (Fig.
1C) and latent gene expression (Fig. 1B) increased between day 4 and
day 12, coincident with the increase in c-Kit levels. Overall, c-Kit
expression in a KSHV-infected culture is inﬂuenced by both the net
level of infected cells and the viral load per infected cell. In vivo, these
parameters could change independently with time and/or due to
exogenous factors.
SCF stimulation induces phosphorylation of c-Kit in KSHV-infected
eDMVECs
To determine if KSHV affects c-Kit receptor activation, the level of
phosphorylation of the c-Kit receptor was measured in mock- and
latently-infected eDMVECs in the presence and absence of exogen-
ous SCF after 24 h of serum starvation. Immunoprecipitations of
infected cell lysates were performed with a c-Kit antibody, and the
resulting immune complexes were then subjected to a phospho-c-Kit
immunoblot (Fig. 4, top panel). To determine the total c-Kit protein
levels, the blot was stripped and re-probed with a c-Kit antibodyn of the c-kit message by KSHV correlated with an increase in c-Kit receptor that was
tometric analysis (B) were performed on Mock-, latent KSHV-, and Ad-c-Kit-infected
noprecipitations (IP) from the indicated cells followed by c-Kit immunoblots (IB). (B,
ected eDMVECs at the indicated days post infection. The solid lines represent cells
with a PE-conjugated isotype control. (B, bottom panel) Flow cytometric analysis for
fection. The solid lines represent cells stained with a c-Kit antibody conjugated to PE
it infected eDMVECs are shown for comparison (far right). The Y-axis represents cell
Flow cytometric analysis for cell surface c-Kit was performed on rKSHV.219-infected
ith a c-Kit antibody conjugated to APC, the dashed line represents GFP negative cells
with an APC-conjugated isotype control antibody.
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occurred in the presence of SCF. The phosphorylation is greatest
following 5 to 20 min of SCF stimulation and diminishes by 40 min.
This decrease in phosphorylation is consistent with ligand-induced
receptor internalization, which is also evidenced by a decrease in
total c-Kit levels. In addition, this pattern of c-Kit phosphorylation is
consistent with SCF stimulation in hematopoietic stem cells
(Wandzioch et al., 2004). These results suggest that while KSHV
infection upregulates c-Kit receptor expression, ligand-independent
activation of the receptor does not occur. Exogenous SCF is still
required for c-Kit phosphorylation, at least under conditions of in
vitro culture.
SCF-induced activation of the Map Kinase Erk 1/2 and Akt pathways is
enhanced in KSHV-infected eDMVECs
Activation of the c-Kit receptor via SCF binding results in a
signaling cascade that involves several kinase pathways, including
MAP Kinase, Erk 1/2, and Akt. To determine whether latent KSHV
infection affected signaling events downstream of c-Kit, the phos-
phorylation states of Erk 1/2 and glycogen synthase kinase 3 (GSK-3),
two effectors in these signaling pathways, were analyzed in the
presence or absence of SCF stimulation. GSK-3 phosphorylation was
used to measure the activation of the Akt pathway because the
phosphorylation of Akt was not reliably detected. Both Erk 1/2 (Fig.
5A, top panel) and GSK-3 (Fig. 5B, top panel) phosphorylations were
upregulated in SCF-stimulated cells, however this activation was
enhanced in KSHV-infected cells, consistent with our previous data
showing increased c-Kit levels in KSHV-infected cells. In the absence
of SCF, phosphorylation levels of both effectors were slightly increased
in KSHV-infected cells. This was likely due to minimal activation of
various other upstream receptors that signal through these effectors.
Total effector protein levels were not signiﬁcantly affected by SCF or
KSHV (Figs. 5A and B, middle panels).
Various kinase inhibitors block SCF-induced activation of Map Kinase
Erk 1/2
To further conﬁrm that c-Kit signaling in KSHV-infected cells was
dependent upon exogenous SCF, the phosphorylation of ERK 1/2 was
analyzed in the presence of kinase inhibitors that act at various stages
of the c-Kit signaling cascade (diagramed in Fig. 6A). As expected, the
tyrosine kinase inhibitors PP1 and Gleevec both prevented Erk 1/2
activation in the presence of SCF (Fig. 6B). Similarly, PD98059 and the
Raf1 inhibitor, which are inhibitors of the Erk1/2 pathway, blocked
Erk 1/2 phosphorylation in a dose dependent manner. Interestingly,
the PI-3 kinase inhibitor LY294002 also showed a decrease in Erk 1/2
activation, which suggests that PI-3 kinase may be involved in the Erk
1/2 pathway as well as the Akt pathway. This observation is consistent
with a study showing that PI-3 kinase may act downstream of Ras in
the Erk 1/2 pathway in SCF-stimulated hematopoietic stem cells
(Wandzioch et al., 2004). None of the kinase inhibitors affected total
Erk 1/2 levels. Our results support KSHV-induced c-Kit expression, but
normal SCF-dependent activation.
Inhibition of kinases in the c-Kit signaling pathway reverses the spindle
phenotype of KSHV-infected eDMVECs
Previous data demonstrated the importance of c-Kit in KSHV-
induced transformation of ECs, as evidenced by prominent spindling
of infected cells and the growth of infected monolayers post-
conﬂuence into multi-layered foci (Moses et al., 2002b). To determine
if the inhibition of various kinases in the c-Kit pathway would affect
the virus-induced transformation phenotype, latently infected, spind-
ling eDMVECs were treated with two concentrations (0.5 μM and
2 μM) of the kinase inhibitors previously described. As shown in Fig.7A, PP1 (tyrosine kinase inhibitor), PD98059 (MEK inhibitor), and
LY294002 (PI-3 kinase inhibitor) all signiﬁcantly inhibited the
spindle-cell phenotype (compare panels 1–3 to panel 5), with the
most robust effect occurring at the higher inhibitor concentration. The
Raf1 inhibitor only partially reversed the phenotype at the 2 μM
concentration (compare panel 4 to panel 5). Restoration of the normal
cell morphology in the presence of inhibitors was not due to a loss of
KSHV-infected cells, as the number of ORF73-expressing cells
(60–80%) was not signiﬁcantly affected (Fig. 6B). These data indicate
that KSHV-induced transformation of ECs is dependent on the
continued activation of Erk 1/2.
c-kit mRNA does not appear to be stabilized in a latent KSHV culture
To address the mechanism of KSHV-induced c-kit upregulation,
we ﬁrst evaluated the half-life of c-kit mRNA in mock or latently
KSHV-infected eDMVECs. The cells were treated with actinomycin D
and RNA was then isolated at regular intervals for 8 h. Fig. 8A depicts
the mRNA levels of both a stable control gene (gapdh) and an
unstable control gene (c-myc) as measured by qPCR. gapdh had a
half-life of N8 h in both mock and KSHV-infected samples, while c-
myc had a half-life of 2 h regardless of infection. As shown in Fig. 8B,
the c-kit mRNA levels for KSHV-infected cells was 10 fold higher
than mock-infected cells, however the half-lives of c-kit mRNA in
both mock and KSHV-infected cells were ∼7 h. These results indicate
that the KSHV-induced increase in c-kit mRNA levels is not a result
of increased mRNA stability.
c-kit upregulation occurs in the LEC, but not the BEC subpopulation of
DMVECs
Because DMVECs obtained from commercial sources are a mixture
of lymphatic and blood ECs, we wanted to know if the upregulation of
c-kit could be induced in both subpopulations of cells. We immorta-
lized the puriﬁed LECs and BECs with papillomavirus E6 and E7 gene
products as previously described for DMVECs (Moses et al., 1999).
These cells were then infected with KSHV and c-kitmRNA levels were
measured at various timepoints by qPCR. Notably, only the infected
LECs showed an upregulation of c-kit (Fig. 9). There was no increase in
c-kit observed in infected BECs although the level of infection was
similar as measured by ORF73 expression (data not shown).
Interestingly, the endogenous levels of c-kit in mock-infected BECs
were comparable to the induced c-kit levels in KSHV-infected LECs
(compare Figs. 9A to B). These results suggest that the c-kit
upregulation is not only virus dependent, but also cell-type depen-
dent. KSHV-induction of c-Kit in LECs correlates with data showing
that KSHV infection of EC sub-types drives the cells to a more
convergent phenotype such that LECs acquire features of BECs and
vice versa (Hong et al., 2004; Wang et al., 2004). Alternately, but not
exclusively, c-Kit induction may reﬂect a transition towards a more
pluripotent, dedifferentiated phenotype.
Discussion
The goal of this study was to understand how c-Kit expression
contributes to the KSHV-induced transformation of ECs, which is, an in
vitro model of KS tumorigenesis. We ﬁrst investigated the kinetics of
c-Kit expression and discovered that infected ECs exhibited signiﬁcant
increases in both c-Kit message and protein levels only after 12 days in
culture, which is well after the establishment of viral latency. The lack
of c-Kit expression at early times after infection suggests a require-
ment for the accumulation of a viral or virally-induced factor(s).
However, our data does not rule out the possibility that a certain viral
load threshold is also required. The latent kinetics of c-kit upregulation
seen with infected eDMVECs was reiterated in primary DMVECs.
However, the levels of c-kitwere signiﬁcantly higher in bothmock and
Fig. 3. Viral spread and c-Kit expression during a KSHV infection. To determine whether c-Kit induction correlated with an increase in KSHV-infected cells, ﬂow cytometric analysis of GFP expression in both mock and rKSHV.219 infected
eDMVECs were performed at the indicated days post infection. The contour plots in the top panel show the percentage of GFP-positive, KSHV-infected cells at each timepoint. The corresponding histograms in the bottom panel show c-Kit
expression of the mock (shaded) or GFP-positive/rHSKV.219-infected (black) cells. The inset rectangles in the top panel are the gates used to denote GFP-positive cells.
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Fig. 4. c-Kit phosphorylation in the presence or absence of SCF. To determine if KSHV
affects c-Kit activation, mock and latent KSHV-infected cells were cultured in the
presence or absence of SCF ligand after 24 h of starvation in minimal medium without
serum. Cell lysates were then prepared, total c-Kit protein was recovered by
immunoprecipitation, and the presence of phosphorylated c-Kit (Y568) was detected
via immunoblot analysis (top panels). The blot was striped and re-probed for total c-Kit
(bottom blots). Infection status and incubation times of SCF stimulation in minutes are
indicated above the blots. Densitometric measurements obtained using Image J
software are shown below each blot. Density values were calculated as background
subtracted mean grey values normalized to the 0 minute samples set to 1.
180 J.L. Douglas et al. / Virology 390 (2009) 174–185infected eDMVECs. This overall increase in c-kit could be due to the
papillomavirus E6/E7 proteins used to immortalize the DMVECs. It
should be noted that E6/E7 alone cannot fully transform cells. Instead,
E6/E7 immortalize cells via the degradation of p53 (Scheffner et al.,
1990) and the inactivation of pRb (Dyson et al., 1989). A synergistic
affect between E6/E7 and v-HA-ras has been implicated in papillo-
mavirus' oncogenic phenotype (Phelps et al., 1988; Riou et al., 1988).
The eDMVEC transformation model was developed to overcome
KSHV's inability to transform primary ECs, so it is not surprising that
E6/E7 might enhance KSHV-induced expression of c-kit. We also
discovered that the KSHV-induced upregulation of c-Kit is a direct
effect of viral infection and not due to a bystander effect from infected
neighbor cells (Fig. 2C).
While c-Kit plays a crucial role in hematopoietic cell develop-
ment, abnormal c-Kit expression or activation leads to the develop-
ment of various cancers. This occurs via temporal dysregulation of
receptor expression (e.g. acute myelongenous leukemia), constitu-
tive activation of the receptor by mutations in the juxtamembrane
and kinase domains (e.g. gastrointestinal stromal cell tumors), or
autocrine secretion of c-Kit's ligand, SCF (e.g. small lung carcino-
mas). We found that the phosphorylation of c-Kit in latent KSHV-
infected cells still required exogenous SCF. In addition, two of the
downstream kinase pathways for c-Kit, Erk 1/2 and Akt were
signiﬁcantly activated only in latently-infected cells treated with SCF.
Previous data has shown that KSHV does not signiﬁcantly increase
SCF expression in eDMVECs (Moses et al., 2002b). Therefore, these
data suggest that KSHV's ability to transform eDMVECs occurs via
the over-expression of the c-Kit receptor rather than constitutive
receptor activation or induction of SCF secretion. Both endogenous
SCF produced from the eDMVECs and exogenous SCF from the
culture medium (human serum contains several nanograms per
milliliter of SCF (Hsu et al., 1997)) would likely provide the stimuli to
maintain c-Kit activation. In KS lesions, the inﬂammatory inﬁltrate
comprised of mast cells and macrophages could provide a continual
source of elevated SCF.
The importance of Erk 1/2 activation for the establishment of
KSHV infection in ECs has been described (Sharma-Walia et al.,
2005). Our data suggests that this activation is also important for the
KSHV-induced transformed spindle phenotype. Using various inhi-
bitors that act on kinases in the Erk 1/2 pathway we were able to
reverse the spindle phenotype. However, we cannot rule out a role
for other kinases such as Akt and JNK 1/2, because the most effective
reversion occurred with PP1 and LY294002, which also inhibit these
pathways. In light of the data suggesting that Erk 1/2 kinase
inhibitors prevented KSHV infection and reduced viral transcription
of both lytic and late viral genes such as ORF50 and ORF73 (Sharma-
Walia et al., 2005), it was surprising that the percentage of infectedcells and the level of ORF73 appeared unaffected by the inhibitor
treatment. Perhaps the profound dependence on Erk 1/2 signaling
for KSHV replication only occurs during the lytic cycle, and once
latency has been established, Erk 1/2 is no longer required for
genome maintenance.
Due to the possibility that the latently expressed Kaposin B protein
stabilizes certain mRNAs (McCormick and Ganem, 2005), we
investigated the ability of KSHV to stabilize the c-kit message. Using
actinomycin D to block transcription, we found that there was no
signiﬁcant difference in the c-kit mRNA half-lives between mock and
KSHV-infected DMVECs. This data suggests that the KSHV-induced
increase in c-kit mRNA levels was not due to enhanced message
stability. Therefore, promoter activation is the most likely mechanism
for the observed upregulation of c-kit, although further analysis will
be necessary to conﬁrm this hypothesis.
In an attempt to determine whether any of the latent gene
products are responsible for the c-Kit induction we established
stable eDMVEC lines expressing the individual latent proteins,
including v-FLIP, v-cyclin, Lana-1 and KapA (data not shown).
Unfortunately, none of the individual latent genes induced any
signiﬁcant levels of c-kit compared to control cells. In addition, none
of the individual latent genes induced the spindle-cell phenotype
normally associated with a latent KSHV infection. This was in
contradiction to a previously published report that v-FLIP could
induce endothelial cell spindling when expressed alone (Grossmann
et al., 2006). Immunoblot analysis conﬁrmed that our v-FLIP cell line
did indeed express v-FLIP protein, so it is not clear what could
account for this discrepancy. Our data suggests that no single latent
gene is responsible for the KSHV-induced c-kit upregulation or the
spindle-cell phenotype associated with transformation. This implies
that either multiple latent genes and/or low lytic gene expression
are responsible.
It has not been conclusively established whether KSHV infects
and reprograms ECs committed to the LEC or BEC lineages, or infects
endothelial cell precursors and inﬂuences their lineage commit-
ment. Interestingly, when we looked at KSHV's ability to induce
c-kit in either the LEC or BEC subpopulations of primary DMVECs,
the levels of c-kit were upregulated in infected LECs over time,
while the amount of c-kit message slightly decreased in infected
BECs. These results are intriguing in light of the potential for KSHV
to reprogram ECs, such that infected LECs mimic untreated BECs and
vice versa (Hong et al., 2004; Wang et al., 2004). c-kit is a
developmentally regulated gene that is highly expressed in
hematopoietic and endothelial progenitor cells, but decreases as
the cells differentiate. Exceptions include mast cells, melanocytes
and umbilical vein ECs (HUVECs) (reviewed in Lennartsson et al.
(2005a)). We show here that normal DMVECs and LECs do not
express any signiﬁcant levels of c-kit message or protein until they
are latently infected with KSHV. Conversely, the endogenous levels
of c-kit in BECs were much higher than in mock-infected LECs. The
differentiation pathway of progenitor ECs leading to either the LEC
or BEC phenotype is not clear; however one possibility is that LECs
may be derived from vascular origins (Adams and Alitalo, 2007).
Perhaps the loss of c-kit expression is part of the normal lymphatic
differentiation pathway, while vascular ECs maintain a higher level
of c-kit expression. The signiﬁcant levels of c-Kit observed in
HUVECs would support this hypothesis (Broudy et al., 1994).
Previously we have shown that the induction of c-kit by KSHV is
necessary for the transformed spindle-cell phenotype observed in
infected eDMVECs. Here we have expanded on these observations
and demonstrate that the KSHV-induced increase in c-kit is
dependent on the establishment of viral latency in an appropriate
endothelial cell type. However, despite this c-kit induction, KSHV
does not appear to directly affect the phosphorylation of the c-Kit
receptor, which remains SCF-dependent. Further characterization of
the mechanism(s) underlying KSHV-induced activation of the c-kit
181J.L. Douglas et al. / Virology 390 (2009) 174–185promoter in ECs will advance our understanding of KSHV-associated
tumorigenesis and may lead to the identiﬁcation of new cellular
targets for KS.
Materials and methods
Cells, viral production, tittering and infections
Primary adult DMVECs, neonatal LECs and BECs (Lonza, Walkers-
ville, MD) were infected with a retroviral vector encoding E6 and E7
from HPV type 16 to generate life-extended DMVECs (eDMVECs) as
previously described (Moses et al., 1999). All endothelial cells were
maintained in human endothelial serum-free medium (SFM) (Invi-
trogen) supplemented with 37 µg/ml endothelial cell growthFig. 5. Activation of c-Kit signaling pathways. To ascertainwhether signaling downstreamof c-
(A, top blot) andphosphorylatedGSK-3 (p-GSK-3) (B, topblot)were performed onmock or KS
Fig. 4. To conﬁrm that total protein levelswere unchanged, the blotswere stripped and reprobe
the phosphorylated protein levels compared to total protein levelswere obtained using Image
to the mock-infected, no SCF sample, which was set to 1.supplement (ECGS) (BD, Franklin Lakes, NJ), 100 UI/ml penicillin,
100 µg/ml streptomycin, 3 mg/ml glutamine (PSG) (Invitrogen), and
10% human serum (Sigma, St. Louis, MO). KSHV used for all infections
was obtained from phorbol 12-myristate 13-acetate (PMA, Sigma)
stimulated body cavity based lymphoma (BCBL) cells (NIH AIDS
Research and Reference Reagent Program, Germantown, MD). To
produce cell-free virus, BCBL cells were cultured in RPMI supplemen-
ted with 1 mM HEPES, 1 mM sodium pyruvate, PSG and 10% fetal
bovine serum (FBS). Cells were stimulated with 20 ng/ml PMA for
4 days and harvested via centrifugation for 10 min at 400×g. The
resulting supernatant was layered onto a 5% sucrose cushion in TNE
(150mMNaCl,10 mMTris pH 8, 2 mMEDTA pH 8) and centrifuged for
2 h at 21,000×g. Viral pellets were resuspended in TNE, at 150th of the
original supernatant volume. Virus titers were determined via aKitwas affected byKSHV infection, immunoblots for phosphorylated Erk1/2 (p-Erk 1/2)
HV-infected cells (3weeks post-infection) that had been treatedwith SCFas described in
dwith antibodies to Erk 1/2 (A, bottomblot) andGSK-3 (B, bottomblot). Quantitation of
J software and are shown in the graphs beloweach of the blots. All values are normalized
Fig. 6. Inhibition of c-Kit signaling. To conﬁrm the activation of c-Kit signaling by KSHV, a series of kinase inhibitors were utilized. The diagram (A) depicts the c-Kit kinase-signaling
pathway and where each inhibitor acts (modiﬁed from Lennartsson et al. (2005a)). A p-Erk 1/2 immunoblot was performed on KSHV-infected cells pre-incubated with the indicated
kinase inhibitors prior to 10 min of SCF stimulation (B, top blot). The blot was stripped and reprobed with antibodies to Erk 1/2 to measure total protein levels (B, bottom blot). The
concentration (μM) of inhibitor is indicated above the blots.
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activator (RTA) assay (Inoue et al., 2003). Brieﬂy, T1H6 cells (a 293T-
based cell line harboring the lacZ (β-galactosidase) gene expressed
from the RTA-dependent PAN promoter) obtained from Dr. Margaret
Offermann (Emory University, Atlanta, GA) were maintained in
DMEM (high glucose) plus 10% FBS, PSG, and 50 µg/ml hygromycin
B. T1H6 cells were seeded at 4×104 cells/well of a 96 well plate
without hygromycin B. Various dilutions of KSHV preparations were
made in 50 µL of serum-free DMEM plus 8 µg/ml polybrene. These
were then added to the cells, followed by a 2 h incubation at 37 °C.
After infection, 50 µl of complete media was added to each well and
the cells were incubated at 37 °C for 3 days. To assay for β-
galactosidase activity, 100 µl of Beta-Glo reagent (Promega, Madison,
WI) was added directly to each well. The plate was incubated at room
temperature for 30 min and then read in a luminometer (Turner
BioSystems). Viral titers were then calculated as β-galactosidase
units/ml. To convert β-galactosidase units into infectious units, the
amount of virus needed to infect approximately 50–80% eDMVECs
was determined. For infections, ECs were seeded at 3×105 cells/well
in 6-well plates. To each well, KSHV was added at 40 β-galactosidase
units/per cell in 1 ml of serum-free medium plus 8 µg/ml polybrene,
and the plates were then centrifuged at 400×g for 30 min (spinocula-tion). The cells were then incubated at 37 °C with 5% CO2 for an
additional 1.5 h. After incubation, 1.5 ml of complete medium was
added. The media was changed every 3–4 days for the duration of the
experiment. The GFP-expressing KSHV, rKSHV.219 was obtained from
Jeff Vieira and produced as described previously (Vieira and O'Hearn,
2004).
Nucleic acid isolation and quantitative Real-time PCR (qPCR)
RNA was isolated from cells using an RNeasy kit (Qiagen, Valencia,
CA) with “on-column”DNAse treatment. RNAwas reversely transcribed
using a Superscript III First Strand Synthesis Kit with random hexamer
priming (Invitrogen). DNAwas isolated from cells using a DNeasy tissue
kit (Qiagen). qPCR was performed using the Power SYBR Green PCR
master mix in an ABI PRISM 7700 Sequence detection system or an ABI
7500 Real-time PCR system (Applied Biosystems, Foster City, CA).
Primer sequences for quantitating cDNA were: gapdh forward 5′-
GTCCACTGGCGTCTTCACCA-3′, gapdh reverse 5′-GTGGCAGTGATGG-
CATGGAC-3′, c-kit forward 5′-CTCAACCATCTGTGAGTCCA-3′, c-kit
reverse 5′-AAGCCGTGTTTGTTGGTGCA, c-myc forward 5′-CTCCT-
ACGTTGCGGTCACAC-3′, c-myc reverse 5′-CCGGGTCGCAGATGAAACTC.
Relative quantitation of gene expression using the standard curve
Fig. 7. Inhibition of KSHV-induced transformation. To investigate whether the kinases in the c-Kit signaling pathway are involved in KSHV-induced transformation of EC, inhibitors at
either 0.5 μM (A, top panels) or 2 μM (A, bottom panels and B) were added to mock and KSHV-infected eDMVECs (21 days post infection). Media plus inhibitor was changed every
2–3 days. After 8 days the cells were (A) photographed live to record any changes in the spindle-cell morphology and then (B) ﬁxed and stained with ORF73 antibodies to assess any
alterations in the level of viral infection. (B, top panels) ORF73 immunoﬂuorescence (B, bottom panels) corresponding phase images.
183J.L. Douglas et al. / Virology 390 (2009) 174–185method was performed as outlined by ABI. For determining DNA copy
numbers, absolute quantitationwas performed using plasmids contain-
ing either a portion of an intron from the gapdh gene or the BamHI
fragment of the ORF26 gene. Primer sequences for determining DNA
copy number were: gapdh forward 5′-TGCCTTCTTGCCTCTTGTCTCT-3′,
gapdh reverse 5′-GGCTCACCATGTAGCACTCACC-3′, ORF26 forward 5′-
AGCCGAAAGGATTCCACCAT-3′, ORF26 reverse 5′-TCCGTGTTGTCT-
ACGTCC-3′. For RNA stability assays, actinomycin D (10 µg/ml, Fisher
Scientiﬁc) was added to the media of mock and KSHV-infected
eDMVECs (3 weeks post infection) for the indicated times. RNA was
isolated and qPCR was performed as described above.
Flow cytometric analysis and immunoﬂuorescence
Mock and KSHV-infected eDMVECs were trypsinized and resus-
pended in ﬂow cytometry buffer (1×phosphate buffered saline (PBS)
plus 3% FBS). The cells were stained for c-Kit with anti-CD117
(104D2) antibody conjugated to phycoerythrin (PE) or the corre-
sponding PE-conjugated isotype control (BD, Franklin Lakes, NJ).
Samples were washed 3 times with ﬂow cytometry buffer and then
analyzed on a FACScalibur (BD). For experiments using rKSHV.219,
the cells were stained for c-Kit with anti-CD117 (104D2) antibody
conjugated to APC or the corresponding APC-conjugated isotype
control (BioLegend, San Diego, CA). ORF73 and ORF59 immunoﬂuor-
escence was performed by ﬁrst ﬁxing the cells in 5% glacial acetic acid
in ethanol for 8 min, washing them 3 times in 1×PBS, and
permeabilizing them in 0.5% Triton-X-100 for 8 min. The cells were
then washed 3 times in 1×PBS, blocked in 20% normal goat serum
(NGS, Sigma), washed once in 1×PBS, and incubated in 1% NGS
containing rabbit anti-ORF73 or mouse anti-ORF59 antibody (kindly
provided by Bala Chandran (Chicago Medical School, North Chicago,
IL)). After primary antibody incubation, the cells were washed 3
times in 1×PBS and incubated in 1% NGS with AlexaFluor 595-conjugated secondary anti-rabbit antibody (Invitrogen), AlexaFluor
488-conjugated secondary anti-mouse antibody (Invitrogen), and
1 µg/ml DAPI. Fluorescent images were obtained from an Axiocam
MRm camera mounted to a Zeiss Axioskop 2 Plus microscope (Zeiss,
Thornwood, NY).
Ligand stimulation, immunoprecipitations, immunoblots and kinase
inhibitors
For ligand stimulation, mock and KSHV-infected ECs were ﬁrst
starved in M199 medium (basal medium for endo-SFM) (Invitrogen)
for 24 h followed by stimulation with 50 ng/ml recombinant human
stem cell factor (SCF) (R & D Systems, Minneapolis, MN) for various
times. The reactions were stopped by incubation on ice and
immediately lysed in either 1% sodium dodecyl sulfate (SDS) buffer
(1% SDS,1mMphenylmethylsulphonyl ﬂuoride (PMSF), 2mM sodium
vanidate, 0.05 M Tris pH 8.0, 1×SigmaFast protease inhibitors,
1×phosphatase inhibitor 2 (Sigma)) for immunoblots or 1% Igepal
lysis buffer (50 mM Tris pH 7.6) plus protease and phosphatase
inhibitors (Sigma) for immunoprecipitations. For c-Kit immunopre-
cipitations, the cell lysates were incubated for 30 min on ice followed
by centrifugation at 10,000×g for 10 min at 4 °C to pellet the cellular
debris. Protein concentrations were determined using a BCA protein
assay (Pierce, Rockford, IL). 250–500 µg total protein was then
precleared with 1 µg of normal mouse IgG and 20 µl of a 25% Protein G
PLUS-Agarose slurry (Santa Cruz Biotech., Santa Cruz, CA) at 4 °C for
30 min. The agarose beads were then pelleted by centrifugation at
1000×g for 5 min at 4 °C. Immunoprecipitations were performed on
the supernatants by adding 1 µg of mouse anti-c-Kit antibody (AB 81,
Santa Cruz Biotech.) for 1 h at 4 °C, followed by the addition of 20 µl of
the 25% Protein G PLUS-Agarose slurry and incubating for 16–20 h
rocking at 4 °C. The immune complexes were then centrifuged at
1000×g for 5 min at 4 °C and washed with 1 ml lysis buffer. The
Fig. 9. c-kit expression in immortalized LECs and BECs. To ascertain whether both
subpopulations of DMVECs can exhibit KSHV-induced c-kit upregulation, RNA samples
184 J.L. Douglas et al. / Virology 390 (2009) 174–185centrifugation and wash steps were repeated 3 times. After the ﬁnal
centrifugation, the supernatant was removed and the pellet was
resuspended in 25 µl protein loading buffer (10% glycerol, 5%
β-mercaptoethanol, 2% SDS, 50 µM Tris pH 6.8 and 0.02% bromophe-
nol blue). The samples were boiled, resolved by SDS-PAGE and
transferred to nitrocellulose membranes. To identify activated c-Kit
the blots were probed with rabbit anti-phospho-c-Kit (Tyr 568/570)
antibodies (Santa Cruz Biotech.) followed by secondary horseradish
peroxidase (HRP) conjugated anti-rabbit antibody. Immune com-
plexes were detected using an ECL Advance kit (GE Healthcare,
Pittsburgh, PA). To detect total c-Kit the phospho-c-Kit antibodies
were removed by soaking the immunoblots in strip buffer (100mM 2-
Mercaptoethanol, 2% SDS, 62.5 mM Tris pH 6.7) at 50 °C for 30 min.
The blots were re-probed with a rabbit anti-c-Kit (H300) antibody
(Santa Cruz Biotech.). For detection of the phosphorylated c-Kit
signaling molecules (phospho-Erk 1/2 and phospho-GSK-3), direct
immunoblots with the following antibodies were used; mouse anti-
phospho-p44/42 Map kinase (Thr202/Tyr204) (E10) and rabbit anti-
phospho-GSK-3 α/β (Ser21/9). For detection of total Erk 1/2 and
GSK-3 levels, the phospho immunoblots were striped and re-probed
with rabbit anti-p44/42 MAP kinase antibody and rabbit anti-GSK-3β
antibody, respectively. All antibodies to signaling molecules were
obtained from Cell Signaling Tech. (Danvers, MA).
For kinase inhibition, ECs that had been previously starved for
24 h were incubated in the following inhibitors or the equivalent
amount of dimethyl sulfoxide (DMSO) for 30 min prior to SCF
stimulation; 4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo
[3,4-d]pyrimidine (PP1), 2′-amino-3′methoxyﬂavone (PD98059),
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002),
5-iodo-3-[(3,5-dibromo-4-hydroxyphenyl)methylene]-2-indolinone
(raf1 kinase inhibitor I) (Biosource, Camarillo, CA) and theFig. 8. c-kitmRNA half-life determination. To determine if KSHV inﬂuences the stability
of c-kit mRNA, latently-infected eDMVECs were treated with actinomycin D and qPCR
was performed on RNA isolated from various times post-treatment. Values are plotted
as total RNA (ng) determined by relative quantitation based on standard curves. c-myc
(A) and c-kit (B) values are normalized to gapdh values. Error bars represent the
standard deviation of duplicate samples and the data shown is representative of three
independent experiments.
from mock (grey bars) and KSHV-infected (black bars) LECs (A) and BECs (B) were
isolated at the indicated times, qPCR for c-kit and gapdhwas performed and c-kit levels
were then normalized to gapdh levels. The data shown is representative of at least two
independent infection timecourses.2-phenylaminopyrimidine derivative STI 571 (Gleevec) provided by
Elisabeth Buchdunger (Novartis, Basel, Switzerland). All compounds
were dissolved in DMSO to make 10 mM stocks.Acknowledgments
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